L Guenther, A Takhar, M Megna, M Sebastian, N Nyholm, H Thoning, L-Å Levin
Issues - Luglio 2022
L Guenther, A Takhar, M Megna, M Sebastian, N Nyholm, H Thoning, L-Å Levin
G Pavia, L Gargiulo, F Spinelli, J Avagliano, M Valenti, R G Borroni, A Costanzo, A Narcisi
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e502-e505E Pezzolo, S Cazzaniga, S Di Leo, L Naldi, PsoReal Study Group
Efficacy and safety of dimethyl fumarate in comparison with conventional therapy for psoriasis: an Italian real-world clinical experience
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e534-e537C Zhang, K Yan, Q Diao, Q Guo, H Jin, S Yang, X Chen, T Lei, J Wu, H Yu, M Zheng, X Gao, R Sinclair, Y Zhu, Q Xu, J Xu
A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis
J Am Acad Dermatol. 2022 Jul;87(1):95-102M D Mansh, A Mulick, S M Langan
The impact of psoriasis and sexual orientation on mental and physical health among adults in the United States
J Am Acad Dermatol. 2022 Jul;87(1):234-237D H Kim, J Y Lee, S I Cho, S J Jo
Risks of comorbidities in patients with palmoplantar pustulosis vs patients with psoriasis vulgaris or pompholyx in Korea
JAMA Dermatol. 2022 Jun 1;158(6):650-660I M Abdelmeniem, I M El Eryan, A Nofal, I F Fouda, S S Omar
Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study
Dermatol Ther. 2022 Jun 22;e15660S Dogra, N Singh, S Kumar, T Narang, S Handa
Comparison of overall efficacy and safety of oral versus subcutaneous methotrexate in severe psoriasis
Dermatol Ther. 2022 Jun 22;e15656G Caldarola, M Galluzzo, N Bernardini, L Calabrese, M Grimaldi, G Moretta, G Pagnanelli, R G Shumak, M Talamonti, L Tofani, S Pallotta, K Peris, C Potenza, C De Simone, E Campione
Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study
Dermatol Ther. 2022 Jun;35(6):e15488S Choi, S Oh, H-S Yoon
Association Between Short-Term PASI90 Achievement and Drug Survival of Biologics in Patients with Psoriasis
Ann Dermatol. 2022 Jun;34(3):173-181H J Ju, H J Park, I H Choi, K H Lee, M Y Kwon, C J Park
Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis
Ann Dermatol. 2022 Jun;34(3):200-205S Takamura, S Sugai, R Taguchi, Y Teraki
Combination therapy of apremilast and biologics in patients with psoriasis showing biologic fatigue
J Dermatol. 2020 Mar;47(3):290-294Jennifer Aileen Ang Tangtatco, Irene Lara-Corrales